| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SRNE sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2022 | Ji Henry | See Remarks | Buy | 88,888 | $2.02 | $179,349.32 | +1.9% | |
| Sep 6, 2022 | Ji Henry | See Remarks | Buy | 55,555 | $1.96 | $108,882.24 | +1.2% | |
| Aug 26, 2022 | Ji Henry | See Remarks | Buy | 33,333 | $2.11 | $70,332.63 | +1.6% | |
| Aug 25, 2022 | Ji Henry | See Remarks | Buy | 22,222 | $2.06 | $45,768.43 | +1.1% | |
| Jun 14, 2022 | Ji Henry | See Remarks | Buy | 10,000 | $1.40 | $13,999.00 | +0.5% | |
| Dec 27, 2021 | Janda Kim | Director | Sale+OE | 3,000 | $5.88 | $17,640.00 | -50.0% | |
| Sep 27, 2021 | Janda Kim | Director | Sale+OE | 42,357 | $8.02 | $339,720.08 | -93.4% | |
| Sep 13, 2021 | Janda Kim | Director | Sale+OE | 8,000 | $8.04 | $64,284.80 | -72.7% | |
| Apr 12, 2021 | Janda Kim | Director | Sale+OE | 1,900 | $6.97 | $13,250.98 | -38.8% | |
| Dec 16, 2020 | Followwill Dorman | Director | Sell | 1,000 | $7.14 | $7,135.00 | -31.9% |